Objective: To investigate the relationship between macular pigment optical density (MPOD) and central retinal thickness (CRT) and choroidal thickness (CT) in patients with central serous chorioretinopathy (CSC). Methods: A total of 82 CSC patients admitted to our hospitals from May 2018 to January 2021 (a total of 82 unilateral eyes) were included as CSC group, and 60 healthy volunteers who received physical examination in the hospital during the same period were selected as control group. The objective measurement of single-wavelength blue light reflection fundus imaging was used to detect MPOD, and optical coherence tomography (OCT) was used to detect CRT and CT values. CT values included subfoveal choroidal thickness (SFCT), temporal choroidal thickness (TCT), and nasal side choroidal thickness (NCT), inferior choroidal thickness (ICT), and superior choroidal thickness (SCT). According to the acute and chronic onset of CSC patients, they were divided into acute group and chronic group. According to the presence or absence of diffuse retinal pigment epithelium (RPE) atrophy, they were divided into RPE atrophy group and no RPE atrophy group. The indicators of the two groups were compared and the correlation of MPOD and CRT, CT in CSC patients were analyzed using Pearson linear correlation. Results: Mean OD and max OD of the affected eye in the CSC group were lower than those of contralateral eyes in the CSC group and the control group, while CRT, SFCT, TCT, and NCT were higher than those of contralateral eyes in the CSC group and the control group (P<0.05). Mean OD and max OD of the chronic group were lower than those of the acute group, and the CRT and SFCT of the RPE atrophy group were lower than those of the no RPE atrophy group (P<0.05). Pearson linear correlation analysis showed that mean OD and max OD of the affected eye of CSC patients were not correlated with CRT, SFCT, TCT, NCT, ICT, SCT (P>0.05). Conclusion: MPOD decrease significantly in CSC patients, and the CT values of CRT and macular fovea, nasal and temporal sides increases, however there is no correlation between MPOD and CRT and CT. |
[1] CHATZIRALLI I, KABANAROU S A, PARIKAKIS E, et al. Risk factors for central serous chorioretinopathy:multivariate approach in a case-control study[J].Curr Eye Res, 2017, 42(7):1-5.
[2] PICCOLINO F C, LUPIDI M, CAGINI C, et al. Choroidal vascular reactivity in central serous chorioretinopathy[J].Invest Ophth Vis Sci, 2018, 59(10):3897-3905.
[3] 刘正峰,潘雪梅.中心性浆液性脉络膜视网膜病变治疗的研究进展[J].山东医药,2019,59(23):104-106.
[4] 李瑞华,张静,聂素珍,等.糖尿病性黄斑水肿的眼底自发荧光和黄斑色素光密度成像[J].中国药物与临床,2020,20(16):2680-2682.
[5] 吴建,蔡啸谷,林彩霞,等.河北永年县农村成年人群黄斑区视网膜厚度的流行病学研究:邯郸眼病研究[J].眼科,2019,28(6):44-51.
[6] 彭清华.中西医结合眼底病学[M].北京:人民军医出版社, 2011:52.
[7] NELIS P, CLEMENS C R, ALTEN F, et al. OCT angiography reveals changes in foveal vessel architecture and foveal flow in central serous chorioretinopathy[J].Acta Ophthalmol, 2017, 95(8):e802-e803.
[8] NICHOLSON B P, ATCHISON E, IDRIS A A, et al. Central serous chorioretinopathy and glucocorticoids:an update on evidence for association[J].Surv Ophthalmol, 2017, 63(1):1-8.
[9] 曹端荣,龚静青,金玲,等.中心性浆液性脉络膜视网膜病变患者荧光素眼底血管造影及预后特征相关性分析[J].临床眼科杂志,2018,26(1):18-21.
[10] 刘志强. 中心性浆液性脉络膜视网膜病变的研究新进展[J].中国实用眼科杂志, 2016, 34(4):309-312.
[11] 吉宇莹, 文峰. 黄斑色素密度与眼底疾病相关性的研究现状[J].中华眼底病杂志, 2020, 36(6):489-493.
[12] 顾鹏, 霍姝佳, 王青,等.视网膜色素变性患者黄斑区微视野检测参数与视网膜结构的相关性分析[J].第三军医大学学报, 2019, 41(3):71-75.
[13] 蒋鹏飞, 彭俊, 欧晨,等.视网膜色素变性的实验研究进展[J].国际眼科杂志, 2020, 20(6):52-55.
[14] 李满, 王冬梅, 徐斌,等.原发性开角型青光眼患者黄斑色素密度与神经节细胞-内丛状层厚度的相关性[J].眼科新进展, 2020, 40(11):50-53.
[15] 包煜芝, 周煜炜, 杨方列,等.糖尿病性视网膜病变术后CRT,SFCT,mALB,MBG,HbA1c水平的变化及相关性[J].基因组学与应用生物学, 2019, 38(2):387-392.
[16] 陈莲, 张鹏. 中心性浆液性脉络膜视网膜病变的治疗进展[J].国际眼科杂志, 2020, 20(1):79-82.
[17] 王薇, 李爽, 李红阳,等.急性中心性浆液性脉络膜视网膜病变患者脉络膜血管指数及中心凹下脉络膜厚度测量分析[J].中华眼底病杂志, 2019, 35(4):353-357.
[18] 徐丽, 王治骞, 庄晓彤. 中心性浆液性脉络膜视网膜病变研究近况及治疗[J].中国实用眼科杂志, 2017, 35(6):553-557. |